Lung Cancer

June 18, 2015June 18, 2015

Moffitt Scientists Develop Process To Assist Personalized Medicine For Lung Cancer Patients

Lung Cancer, News

Researchers from the Moffitt Cancer Center are collaborating with the Lung Cancer Mutation Consortium and have advanced a process to assess mutated genes in lung adenocarcinoma to aid in better selection of personalized ... Read more

June 11, 2015June 11, 2015

Surgery/Chemotheray/Radiotheray Combination May Increase Patients with Advanced Lung Cancer Survival

Lung Cancer, News

In a new study entitled “Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer,” authors performed a retrospective analysis on the benefits of adding ... Read more

June 8, 2015June 8, 2015

Lung Cancer Patients Risk for Venous Thromboembolism Identified Through Caprini Model

Lung Cancer, News

New results from a research project at Boston University School of Medicine suggest that a model currently used to assess the risk of venous thromboembolism, a disease that includes both deep ... Read more

June 4, 2015October 28, 2015

Protein AKAP4 Revealed as Potential, New Lung Cancer Biomarker

Lung Cancer, News

In a new study entitled “AKAP4 is a circulating biomarker for non-small cell lung cancer,” researchers at The Wistar Institute discovered the protein AKAP4 as a potential new biomarker for non-small cell lung ... Read more

June 4, 2015June 4, 2015

FDA Accepts Supplemental Biologics License Application For KEYTRUDA

Lung Cancer, News

Merck recently announced that the U.S. Food and Drug Administration (FDA) has agreed to review a supplemental Biologics License Application (sBLA) for the company’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab), with the ... Read more

June 2, 2015June 2, 2015

Opdivo (Nivolumab) Treatment Found to Offer Higher Overall Survival in Patients With Non-Small Cell Lung Cancer

Lung Cancer, News

Promising data on a Phase III trial (NCT01673867) to assess the safety and efficacy of nivolumab in the treatment of non-squamous non-small cell lung cancer (NSCLC) was recently presented at ... Read more

May 25, 2015May 26, 2015

Novartis Announces Extended Progression-free Survival in Phase III Afinitor Trial For Advanced Lung Neuroendocrine Tumors

Lung Cancer, News

Novartis recently announced that RADIANT-4, a prospective, double-blind, randomized, Phase III study that evaluated the efficacy and safety of Afinitor (everolimus) tablets used together with best supportive care, has met its ... Read more

May 15, 2015May 15, 2015

Veracyte Publishes Results of Percepta Bronchial Genomic Classifier for Lung Cancer

Lung Cancer, News

Veracyte, a biotech company working in the field of molecular cytology with a focus on genomic solutions that resolve diagnostic ambiguity, recently announced the publication of a study on the journal BMC ... Read more

May 14, 2015May 14, 2015

RAFA Laboratories Partner With OSE Pharma On Tedopi Lung Therapy

Lung Cancer, News

French biotech company OSE Pharma SA and Israeli-based RAFA laboratories have signed an exclusive long term agreement for the investigational lung cancer medication Tedopi. The contract includes registration, marketing, distribution and sales ... Read more

May 12, 2015May 12, 2015

Psychologists Seek to Improve Online Health Information for Lung Cancer

Lung Cancer, News

Results from recent research conducted by PhD student Julia Mueller from the School of Nursing, Midwifery and Social Work at The University of Manchester were presented during the British Psychological ... Read more